Parker Waichman LLP

FDA Orders Drug Safety Plans

The US Food and Drug Administration (FDA) just named 25 drugs and biologic products, including some well-known and popular medications, whose makers will be required to submit safety plans later this year.  The product list as published in the Federal Register and includes the multiple myeloma medication thalidomide (Thalomid), the anti-psychotic medication clozapine (Clozaril), and […]

The US Food and Drug Administration (FDA) just named 25 <"https://www.yourlawyer.com/practice_areas/defective_drugs">drugs and biologic products, including some well-known and popular medications, whose makers will be required to submit safety plans later this year.  The product list as published in the Federal Register and includes the multiple myeloma medication thalidomide (Thalomid), the anti-psychotic medication clozapine (Clozaril), and the abortifacient drug mifepristone (Mifeprex).  The plans, called Risk Evaluation and Mitigation Strategy—or REMS—plan must be submitted to the FDA no later than September 21 on pain of “enforcement action,” which includes monetary penalties, the FDA said.

The move comes under amendments to the Food, Drug, and Cosmetic Act, which was passed last year and which also gave the FDA authority to require a REMS plan when a drug first goes to market or when the FDA is made aware of new safety data.  The goal of REMS is to ensure the safe use of medications that have risks if used improperly, according to Jane Axelrad of the FDA’s Center for Drug Evaluation and Research.  “These safety plans allow patients to have continued access to certain medicines for which there are safety concerns that can be managed through appropriate use,” Axelrad said.  “The FDA approved the drugs identified today before the new law was passed, and they will now be brought under the new statutory authority to require and enforce REMS,” she added.

Drugs are deemed to need an REMS if:

•    Clinician prescribers need specific training or experience or are specially certified.
•    Pharmacies, practitioners, or healthcare settings dispenses the drug are specially certified.
•    The drug is dispensed to patients only in certain healthcare settings, such as hospitals.
•    The drug is dispensed to patients with evidence or other documentation of safe use conditions, such as laboratory test results.
•    Patients using the drug are subject to certain monitoring or are enrolled in a registry.

The drugs on the list were all approved before March 25; however, medications approved after this date will have the REMS requirement imposed at the time of approval, the FDA said.  Drugs that will need an REMS are:

Abarelix (Plenaxis), which is approved but not currently sold in the U.S.
Alosetron (Lotronex)
Ambrisentan (Letairis)
Bosentan (Tracleer)
Several formulations of Clozapine (Clozaril and Fazaclo ODT)
Dofetilide (Tikosyn)
Eculizumab (Soliris)
Fentanyl PCA (Ionsys), which is approved but not currently not sold in the U.S.
Fentanyl citrate (Actiq)
Several formulations of isotretinoin (Accutane, Amnesteem, Claravis, Sotret)
Lenalidomide (Revlimid)
Mifepristone (Mifeprex)
Natalizumab (Tysabri)
The live smallpox (vaccinia) vaccine (ACAM2000)
Sodium oxybate (Xyrem)
Thalidomide (Thalomid)

Recently, lawmakers were concerned by the rash of drug recalls and have been urging regulators to implement standards to alleviate these issues.  This influencing of actual drug usage is a change from the FDA’s traditional role as that of monitor, or gatekeeper, for new drugs and medical products.  Until now, the FDA developed the labels that detail how drugs are meant to be used, but it left the final prescribing decisions to doctors, who are not bound by federal guidelines and can prescribe medications for off-label—uses other than what is FDA approved—uses.

What Our Clients Say About Us
We have worked with thousands of clients and we appreciate them and their positive reviews. Here are just a few recent client reviews...
5 Star Reviews 150
So grateful for the great team at Parker Waichman. Julie, Maryann and Jorge were there for me from the very beginning treating me like family. They kept full communication with me through the entire process and took all the weight off my shoulders. Thanks again to you all!
Jorbel Mateo
2 months ago
5 Star Reviews 150
Parker Waichman was extremely professional and helpful in handling our WTC case. Christina Morace, in particular, was amazing in helping us complete all the necessary documents and clearly explaining the process for our claim. Christina did a great job communicating with us via the phone and email. She set the proper expectations and the result was getting our claim approved. Thank you again and we clearly recommend using Parker Waichman.
Kevin Killian
10 months ago
5 Star Reviews 150
Service was very good. People always returned calls and answered my questions and concerns.
Dom Lanzisera
4 years ago

Why Choose Us to Help You?

We Take Care of Everything
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
No Recovery = No Legal Fees
We work on a contingency-fee basis, meaning that we only get paid from a portion of your settlement or jury award. If you don't get compensation, you owe us nothing.
Decades of Experience
Your situation is stressful enough: Let us take on the deadlines, paperwork, investigation, and litigation. We'll handle every detail so you don't have to worry.
Respected by Our Peers
Judges, insurance adjusters, and fellow attorneys all speak highly of our skills, and we've earned numerous accolades, including a flawless rating from AVVO.
We Have Many Locations To Serve You
We have the experience and the skilled litigators to win your case. Contact us and speak with a real attorney who can help you.
Long Island – Nassau
Parker Waichman LLP
6 Harbor Park Drive
Port Washington, NY 11050
Long Island – Suffolk
Parker Waichman LLP
201 Old Country Road – Suite 145
Melville, NY 11747
New York
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038
Queens
Parker Waichman LLP
118-35 Queens Boulevard, Suite 400
Forest Hills, NY 11375
Brooklyn
Parker Waichman LLP
300 Cadman Plaza West
One Pierrepont Plaza, 12th Floor
Brooklyn, NY 11201
New Jersey
Parker Waichman LLP
80 Main Street, Suite 265
West Orange, NJ 07052
Florida
Parker Waichman LLP
27299 Riverview Center Boulevard
Suite 108
Bonita Springs, FL 34134
Nationwide Service
Parker Waichman LLP
59 Maiden Lane, 6th Floor
New York, NY 10038